|
RPL23AP7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.029800E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.010800E-01 |
| Normal-vs-Stage2 |
1.654460E-02 |
| Normal-vs-Stage3 |
1.813650E-02 |
| Normal-vs-Stage4 |
2.482200E-02 |
| Stage1-vs-Stage2 |
2.993800E-02 |
| Stage1-vs-Stage3 |
4.065700E-02 |
| Stage1-vs-Stage4 |
5.501600E-02 |
| Stage2-vs-Stage3 |
5.434800E-01 |
| Stage2-vs-Stage4 |
6.523800E-01 |
| Stage3-vs-Stage4 |
8.948400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.996200E-02 |
| Normal-vs-AfricanAmerican |
6.262200E-03 |
| Normal-vs-Asian |
3.476800E-01 |
| Caucasian-vs-AfricanAmerican |
1.901730E-02 |
| Caucasian-vs-Asian |
6.536000E-01 |
| AfricanAmerican-vs-Asian |
6.738600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.935800E-02 |
| Normal-vs-Female |
6.313500E-02 |
| Male-vs-Female |
8.379000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.579200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.481840E-01 |
| Normal-vs-Age(61-80Yrs) |
1.785670E-02 |
| Normal-vs-Age(81-100Yrs) |
1.711630E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.131800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.981800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.426100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.554600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.786100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.598590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.912800E-01 |
| Normal-vs-Grade 2 |
9.732200E-02 |
| Normal-vs-Grade 3 |
2.813600E-02 |
| Normal-vs-Grade 4 |
9.391800E-02 |
| Grade 1-vs-Grade 2 |
3.000400E-01 |
| Grade 1-vs-Grade 3 |
2.356200E-01 |
| Grade 1-vs-Grade 4 |
2.573400E-01 |
| Grade 2-vs-Grade 3 |
4.346200E-01 |
| Grade 2-vs-Grade 4 |
6.700200E-01 |
| Grade 3-vs-Grade 4 |
8.899000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.695900E-02 |
| Normal-vs-ccB subtype |
7.505700E-02 |
| ccA subtype-vs-ccB subtype |
7.896000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.409960E-02 |
| Normal-vs-N1 |
4.982200E-01 |
| N0-vs-N1 |
5.947600E-01 |
|
|
